Nucleic Acid-conjugated Carbohydrate Nanobiosensors: A Multimodal Tool for Disease Diagnosis.


Journal

Current pharmaceutical design
ISSN: 1873-4286
Titre abrégé: Curr Pharm Des
Pays: United Arab Emirates
ID NLM: 9602487

Informations de publication

Date de publication:
2022
Historique:
received: 14 10 2021
accepted: 25 02 2022
pubmed: 2 5 2022
medline: 12 10 2022
entrez: 1 5 2022
Statut: ppublish

Résumé

Nucleic acid-based carbohydrate sensors (NAbCSs) constitute a strategy involving nucleic acids as recognition elements for the development of a unique, stable, sensitive, mono- or multimodal detection system in the field of nanomedicine, gas sensing, and gene therapy. Thus, this advanced platform for next-generation investigation compromises cost-effective, wearable, and noninvasive sensing devices as diagnostics in healthcare. This review article highlights the importance of NAbCSs and explores the novel applications of sensors fabricated via the conjugation of nucleic acids and carbohydrates. Additionally, advances in smart portable devices, like smartphones, printers, and digital multimeters, are summarized, followed by the challenges involved in the development of futuristic sensing tools. A novel platform has been unfolded for the detection of different chemical toxins (like aflatoxin B1, ochratoxin A) and biomarkers (like miRNA in cancer) present in biosamples, food and biowarfare agents. The potential applications of biosensing in the areas of miniaturization, reusability, rapid, point-of-care or portable for home analysis techniques, cost-effective, eco-friendly, high throughput and personalized sensors for qualitative analysis of target analyte/s in bio-fluids and food have been explored. NAbCSs provide real-time monitoring of biosamples qualitatively and semi-quantitatively (luminometer, fluorimeter, etc.) in the absence of trained personnel. Explorations of NAbCSs encompass advantages in remote resource-limited access areas with simultaneous monitoring via smart devices for multiple analytes with greater precision, sensitivity, and selectivity.

Sections du résumé

BACKGROUND
Nucleic acid-based carbohydrate sensors (NAbCSs) constitute a strategy involving nucleic acids as recognition elements for the development of a unique, stable, sensitive, mono- or multimodal detection system in the field of nanomedicine, gas sensing, and gene therapy. Thus, this advanced platform for next-generation investigation compromises cost-effective, wearable, and noninvasive sensing devices as diagnostics in healthcare.
OBJECTIVE
This review article highlights the importance of NAbCSs and explores the novel applications of sensors fabricated via the conjugation of nucleic acids and carbohydrates. Additionally, advances in smart portable devices, like smartphones, printers, and digital multimeters, are summarized, followed by the challenges involved in the development of futuristic sensing tools.
METHODS
A novel platform has been unfolded for the detection of different chemical toxins (like aflatoxin B1, ochratoxin A) and biomarkers (like miRNA in cancer) present in biosamples, food and biowarfare agents. The potential applications of biosensing in the areas of miniaturization, reusability, rapid, point-of-care or portable for home analysis techniques, cost-effective, eco-friendly, high throughput and personalized sensors for qualitative analysis of target analyte/s in bio-fluids and food have been explored.
CONCLUSION
NAbCSs provide real-time monitoring of biosamples qualitatively and semi-quantitatively (luminometer, fluorimeter, etc.) in the absence of trained personnel. Explorations of NAbCSs encompass advantages in remote resource-limited access areas with simultaneous monitoring via smart devices for multiple analytes with greater precision, sensitivity, and selectivity.

Identifiants

pubmed: 35490323
pii: CPD-EPUB-122968
doi: 10.2174/1381612828666220427140110
doi:

Substances chimiques

Biological Warfare Agents 0
Biomarkers 0
Carbohydrates 0
MicroRNAs 0
Nucleic Acids 0
Aflatoxin B1 9N2N2Y55MH

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

2461-2477

Informations de copyright

Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.

Auteurs

Maithili Kantak (M)

Pharmaceutical Sciences, Narsee Monjee Institute of Management Studies, Mumbai, India.

Pravin Shende (P)

Pharmaceutical Sciences, Narsee Monjee Institute of Management Studies, Mumbai, India.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH